advertisement
 |
|
Top Stories
Following a vote by member states in favor of Amsterdam as the agency’s new headquarters, the relocation will take place over the next 16 months, with operations expected to start up in March 2019.
/ read more /
Manufacturers and trading partners struggle to meet drug tracking requirements
/ read more /
|
|
PharmTech 2017 Employment Trends
The editors of Pharmaceutical Technology invite you to participate in the annual employment survey for individuals involved in bio/pharmaceutical development, formulation, or manufacturing.
Take the Survey |
|
|
|
advertisement
 |
Subscribe
Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.
subscription offers |
 |
|
advertisement
  |
|
advertisement
 |
|
Industry News
The company is recalling product because of microbial contamination.
/ read more /
Pharma trends translate into increased need for not only external partners, but those will capabilities that can help advance today’s drug development and manufacturing challenges.
/ read more /
More Industry News
|
|
|
Supplier News
The acquisition gives GE Healthcare access to a nanofiber-based platform purification technology that can offer improvements in biopharmaceutical productivity.
/ read more /
Avista Pharma Solutions facility and equipment upgrades at its Longmont, Colorado facility support processing of potent compounds.
/ read more /
More Supplier News
|
|
|
advertisement
 |
|
Bio/Pharma News
In the wake of generic-drug pricing pressure and declining revenues, Teva has restructured its commercial business and made executive leadership changes.
/ read more /
The joint venture will focus on the discovery, development, and commercialization of potential new drugs for the global market as well as speed delivery of new medicines to China.
/ read more /
More Bio/Pharma News
|
|
|
Regulatory News
The new guidelines discuss GMPs and patient protection specific to advanced therapy medicinal products.
/ read more /
Ontruzant is the first biosimilar of Roche’s Herceptin (trastuzumab) to be approved in Europe.
/ read more /
More Regulatory News
|
|
|
|
Drug Delivery
Ralph Gosden, head of product development at Catalent’s Swindon, United Kingdom site, explains the opportunities of orally disintegrating tablets as a patient-centric dosage form.
/ read more /
|
|
|
|
|
Peer-Reviewed Research
In Part I of this article series, the regression control chart method for identifying out-of-trend data in pharmaceutical stability studies is investigated, and an improved approach is suggested.
/ read more /
|
|
|
|
Analytics
Inadequate endotoxin testing places patients at risk. Knowing the relative strengths and weaknesses of available test methods is crucial to maintaining quality and safety.
/ read more /
|
|
|
Events
December 11–12, 2017
December 12–13, 2017
February 7–8, 2017
more events |
|
|
eBOOKS
 |
New technologies, including single-use systems, are leading the push for faster production and higher titers. At the same time, ensuring quality in raw materials and water systems, and controlling contamination are paramount. In this Biologics and Sterile Manufacturing eBook, the editors explore key technology, process, and operational topics. |
|
|
|
|
|
